Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Jan;47(1):1–13. doi: 10.1038/bjc.1983.1

The response to chemotherapy of a variety of human tumour xenografts.

G G Steel, V D Courtenay, M J Peckham
PMCID: PMC2011242  PMID: 6336942

Abstract

The results of a series of projects on the cytotoxic drug response of human tumour xenografts are compared. All were performed in one laboratory, using conventional CBA mice that were usually immunosuppressed by thymectomy, cytosine arabinoside treatment, and whole-body irradiation. Results on human tumours arising in 9 anatomical sites are included, with the main emphasis on colo-rectal, pancreas, breast, lung and testis carcinomas, also melanomas. Growth acceleration during successive passage of most of these tumour types was observed. When therapeutic response was measured by a growth-delay method there were wide differences in response to chemotherapy. Testicular teratomas and small-cell lung tumours responded well; breast tumours showed modest response; melanomas, colo-rectal tumours and non-small-cell lung tumours responded poorly. Studies of clonogenic cell survival were made in 11 xenografted tumour lines. They confirmed the range of responsiveness and tendency towards individuality of the growth delay data. Cell survival in most cases was exponentially related to drug dose. This compilation of a large amount of experimental data supports the belief that human tumour xenografts broadly maintain the level of chemotherapeutic responsiveness of the source tumours in man.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey M. J., Gazet J. C., Peckham M. J. Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer. 1980 Oct;42(4):524–529. doi: 10.1038/bjc.1980.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bailey M. J., Gazet J. C., Smith I. E., Steel G. G. Chemotherapy of human breast-carcinoma xenografts. Br J Cancer. 1980 Oct;42(4):530–536. doi: 10.1038/bjc.1980.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bateman A. E., Selby P. J., Steel G. G., Towse G. D. In vitro chemosensitivity tests on xenografted human melanomas. Br J Cancer. 1980 Feb;41(2):189–198. doi: 10.1038/bjc.1980.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Courtenay V. D., Mills J., Steel G. G. The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts. Br J Cancer. 1982 Sep;46(3):436–439. doi: 10.1038/bjc.1982.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Einhorn L. H. Combination chemotherapy with cis-dichlorodiammineplatinum(II) in disseminated testicular cancer. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1659–1662. [PubMed] [Google Scholar]
  7. Freireich E. J., Gehan E. A., Rall D. P., Schmidt L. H., Skipper H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966 May;50(4):219–244. [PubMed] [Google Scholar]
  8. Hamburger A. W. Use of in vitro tests in predictive cancer chemotherapy. J Natl Cancer Inst. 1981 Jun;66(6):981–988. doi: 10.1093/jnci/66.6.981. [DOI] [PubMed] [Google Scholar]
  9. Hengst J. C., Mokyr M. B., Dray S. Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors. Cancer Res. 1981 Jun;41(6):2163–2167. [PubMed] [Google Scholar]
  10. Houghton J. A., Taylor D. M. Growth characteristics of human colorectal tumours during serial passage in immune-deprived mice. Br J Cancer. 1978 Feb;37(2):213–223. doi: 10.1038/bjc.1978.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Houghton J. A., Taylor D. M. Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice. Br J Cancer. 1978 Feb;37(2):199–212. doi: 10.1038/bjc.1978.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kemeny N., Yagoda A., Braun D., Jr, Golbey R. Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep). Cancer. 1980 Mar 1;45(5):876–881. doi: 10.1002/1097-0142(19800301)45:5<876::aid-cncr2820450509>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  13. Kopper L., Steel G. G. The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res. 1975 Oct;35(10):2704–2713. [PubMed] [Google Scholar]
  14. Mantovani A., Polentarutti N., Luini W., Peri G., Spreafico F. Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice. J Natl Cancer Inst. 1979 Jul;63(1):61–66. [PubMed] [Google Scholar]
  15. Millar J. L., Blackett N. M., Hudspith B. N. Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents. Cell Tissue Kinet. 1978 Sep;11(5):543–553. doi: 10.1111/j.1365-2184.1978.tb00826.x. [DOI] [PubMed] [Google Scholar]
  16. Moshakis V., Bailey M. J., Ormerod M. G., Westwood J. H., Neville A. M. Localization of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigen. Br J Cancer. 1981 May;43(5):575–581. doi: 10.1038/bjc.1981.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nowak K., Peckham M. J., Steel G. G. Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer. 1978 Apr;37(4):576–584. doi: 10.1038/bjc.1978.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Phelps T. A., Blackett N. M. Protection of intestinal damage by pretreatment with cytarabine (cytosine arabinoside). Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1617–1620. doi: 10.1016/0360-3016(79)90784-3. [DOI] [PubMed] [Google Scholar]
  19. Pickard R. G., Cobb L. M., Steel G. G. The growth kinetics of xenografts of human colorectal tumours in immune deprived mice. Br J Cancer. 1975 Jan;31(1):36–45. doi: 10.1038/bjc.1975.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Povlsen C. O., Jacobsen G. K. Chemotherapy of a human malignant melanoma transplanted in the nude mouse. Cancer Res. 1975 Oct;35(10):2790–2796. [PubMed] [Google Scholar]
  21. Rae-Venter B., Reid L. M. Growth of human breast carcinomas in nude mice and subsequent establishment in tissue culture. Cancer Res. 1980 Jan;40(1):95–100. [PubMed] [Google Scholar]
  22. Reeves B. R., Houghton J. A. Serial cytogenetic studies of human colonic tumour xenografts. Br J Cancer. 1978 Apr;37(4):612–619. doi: 10.1038/bjc.1978.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rofstad E. K., Brustad T. Radiosensitizing effect of misonidazole in acute and fractionated irradiation of a human osteosarcoma xenograft. Int J Radiat Oncol Biol Phys. 1980 Sep;6(9):1163–1167. doi: 10.1016/0360-3016(80)90169-8. [DOI] [PubMed] [Google Scholar]
  24. Rofstad E. K., Brustad T. The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse. Br J Radiol. 1978 May;51(605):381–386. doi: 10.1259/0007-1285-51-605-381. [DOI] [PubMed] [Google Scholar]
  25. Sebesteny A., Taylor-Papadimitriou J., Ceriani R., Millis R., Schmitt C., Trevan D. Primary human breast carcinomas transplantable in the nude mouse. J Natl Cancer Inst. 1979 Dec;63(6):1331–1337. [PubMed] [Google Scholar]
  26. Selby P. J., Courtenay V. D., McElwain T. J., Peckham M. J., Steel G. G. Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. Br J Cancer. 1980 Sep;42(3):438–447. doi: 10.1038/bjc.1980.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shorthouse A. J., Carter S. M., Ellison M. L. Tumor marker production in human bronchial carcinoma xenografts. Oncodev Biol Med. 1982;3(4):273–281. [PubMed] [Google Scholar]
  28. Shorthouse A. J., Jones J. M., Steel G. G., Peckham M. J. Experimental combination and single-agent chemotherapy in human lung-tumour xenografts. Br J Cancer. 1982 Jul;46(1):35–44. doi: 10.1038/bjc.1982.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shorthouse A. J., Smyth J. F., Steel G. G., Ellison M., Mills J., Peckham M. J. The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg. 1980 Oct;67(10):715–722. doi: 10.1002/bjs.1800671011. [DOI] [PubMed] [Google Scholar]
  30. Smith I. E., Courtenay V. D., Gordon M. Y. A colony-forming assay for human tumour xenografts using agar in diffusion chambers. Br J Cancer. 1976 Nov;34(5):476–483. doi: 10.1038/bjc.1976.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Steel G. G., Courtenay V. D., Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978 Feb;37(2):224–230. doi: 10.1038/bjc.1978.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stephens T. C., Peacock J. H. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Br J Cancer. 1977 Sep;36(3):313–321. doi: 10.1038/bjc.1977.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wittes R. E., Wittes J. T., Golbey R. B. Combination chemotherapy in metastatic malignant melanoma: a randomized study of three DTIC-containing combination. Cancer. 1978 Feb;41(2):415–421. doi: 10.1002/1097-0142(197802)41:2<415::aid-cncr2820410206>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES